SCHEMBL904058

SCHEMBL904058

Nc1nc(C(=O)N2Cc3ccccc3C2)c2cc(-c3ccccc3CN3CCCC3)ccc2n1

nearest known ligand 0.81

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.81
HSP90AB1 P08238 3/20 0.59
ADORA2A P29274 4/20 0.43
ADORA1 P30542 4/20 0.43
DHODH Q02127 2/20 0.41
APP P05067 1/20 0.41
PIK3CD O00329 1/20 0.39
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3093432 0.93 HSP90AA1 (0.75) HSP90AA1HSP90AB1ADORA2AADORA1F10
SCHEMBL13144877 0.92 HSP90AA1 (0.74) HSP90AA1HSP90AB1ADORA2AADORA1DHODH
SCHEMBL3080612 0.92 HSP90AA1 (0.74) HSP90AA1HSP90AB1ADORA2AADORA1DHODH
SCHEMBL904155 0.91 HSP90AA1 (0.73) HSP90AA1HSP90AB1ADORA2AADORA1F2
SCHEMBL904228 0.89 HSP90AA1 (1.00) HSP90AA1HSP90AB1
SCHEMBL904229 0.89 HSP90AA1 (0.69) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL904033 0.88 HSP90AA1 (0.70) HSP90AA1HSP90AB1ADORA2AADORA1DHODH
SCHEMBL904224 0.88 HSP90AA1 (0.70) HSP90AA1HSP90AB1F2F10
SCHEMBL15091206 0.88 HSP90AA1 (0.70) HSP90AA1HSP90AB1DHODHF2F10
SCHEMBL904222 0.88 HSP90AA1 (0.70) HSP90AA1HSP90AB1DHODHF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US claimed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US claimed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
WO-2012041435-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 HSP90AA1 3/4885HSP90AB1 2/4885ADORA2A 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.